• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Telomir Pharmaceuticals, Inc. - Common Stock (NQ:TELO)

    1.360 -0.040 (-2.84%)
    Streaming Delayed Price Updated: 11:10 AM EDT, Mar 13, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 21,152
    Open 1.400
    Bid (Size) 1.360 (2,700)
    Ask (Size) 1.400 (1,000)
    Prev. Close 1.400
    Today's Range 1.360 - 1.400
    52wk Range 1.050 - 5.400
    Shares Outstanding 34,380,971
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    BioMedNewsBreaks – Telomir Pharmaceuticals (NASDAQ: TELO) Reports Iron-Dependent Tumor Cell Mortality in TNBC Models
    Via Investor Brand Network
    News headline image
    Telomir Pharmaceuticals Demonstrates Broad Tumor Cell Mortality in Human Triple-Negative Breast Cancer Models
    Via ACCESS Newswire

    Performance

    YTD
    +1.5%
    +1.5%
    1 Month
    +16.3%
    +16.3%
    3 Month
    -8.1%
    -8.1%
    6 Month
    -0.7%
    -0.7%
    1 Year
    -72.5%
    -72.5%

    More News

    Read More
    BioMedNewsBreaks – Telomir Pharmaceuticals (NASDAQ: TELO) Reports New Cellular Data Demonstrating Coordinated Intracellular Zinc Increase and Iron Reduction With Telomir-Zn
    Via Investor Brand Network
    News headline image
    Telomir Pharmaceuticals Reports New Data Supporting an Epigenetic Modulation Mechanism Implicated in Cancer and Aging
    Via ACCESS Newswire
    Why Telomir Pharmaceuticals Stock Is Rising 40% Premarket Today ↗
    Via Stocktwits
    MissionIRNewsBreaks – Telomir Pharmaceuticals (NASDAQ: TELO) Reports Positive Telomir-1 Results In TNBC Zebrafish Xenograft Study
    Via Investor Brand Network
    News headline image
    Telomir Pharmaceuticals Announces Telomir-1 Significantly Reduced Tumor Growth and Metastases in Aggressive Triple-Negative Breast Cancer Animal Models
    Via ACCESS Newswire
    InvestorNewsBreaks – Telomir Pharmaceuticals (NASDAQ: TELO) Reports Favorable IND-Enabling GLP Safety Results for Telomir-1
    Via Investor Brand Network
    News headline image
    Telomir Pharmaceuticals Reports Favorable IND-Enabling GLP Safety Results for Telomir-1 Supporting First-in-Human Clinical Development
    Via ACCESS Newswire
    News headline image
    Telomir Pharmaceuticals Reports New Data Showing Telomir-1 Significantly Reduces PSA Levels in Human Prostate Cancer Cells
    Via ACCESS Newswire
    News headline image
    TELO Stock Jumps Pre-market After Early Study Results Show Leukemia Cell Death ↗
    Via Stocktwits
    News headline image
    Telomir Pharmaceuticals Announces Telomir-1 Kills Aggressive Human Leukemia Cells
    Via ACCESS Newswire
    News headline image
    Telomir Pharmaceuticals Reports Telomir-1 Outperforms FDA-Approved Gold-Standard Iron Chelator Deferoxamine (DFO) in Reducing Intracellular Iron in a Human Cell Line
    Via ACCESS Newswire
    News headline image
    Telomir Pharmaceuticals Reports New Data Showing Telomir-1 Resets Cancer's “Kill-and-Clean” Defense Systems in an Aggressive Prostate Cancer Model, Outperforming Rapamycin and Chemo
    Via ACCESS Newswire
    News headline image
    Telomir Pharmaceuticals Executes Binding LOI for Worldwide Rights to Telomir-1, Positioning the Company for Global Market Expansion and Value Growth
    Via ACCESS Newswire
    News headline image
    Telomir Pharmaceuticals Announces New Data Showing That Telomir-1 Kills Aggressive Pancreatic Cancer Cells, One of the Deadliest Forms of Cancer
    Via ACCESS Newswire
    News headline image
    12 Health Care Stocks Moving In Thursday's After-Market Session ↗
    Via Benzinga
    News headline image
    Thursday's after hours session: top gainers and losers ↗
    Via Chartmill
    News headline image
    Telomir Pharmaceuticals Touts Promising Action From Its Lead Breast Cancer Drug ↗
    Via Benzinga
    News headline image
    12 Health Care Stocks Moving In Thursday's Intraday Session ↗
    Via Benzinga
    News headline image
    Which stocks are moving before the opening bell on Thursday? ↗
    Via Chartmill
    News headline image
    12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
    Via Benzinga
    News headline image
    Telomir Pharmaceuticals Reports Discovery That Telomir-1 Selectively Kills Aggressive Triple-Negative Breast Cancer Cells
    Via ACCESS Newswire
    News headline image
    Why Richardson Electronics Shares Are Trading Higher By Over 20%; Here Are 20 Stocks Moving Premarket ↗
    Via Benzinga
    News headline image
    12 Health Care Stocks Moving In Wednesday's After-Market Session ↗
    Via Benzinga

    Frequently Asked Questions

    Is Telomir Pharmaceuticals, Inc. - Common Stock publicly traded?
    Yes, Telomir Pharmaceuticals, Inc. - Common Stock is publicly traded.
    What exchange does Telomir Pharmaceuticals, Inc. - Common Stock trade on?
    Telomir Pharmaceuticals, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Telomir Pharmaceuticals, Inc. - Common Stock?
    The ticker symbol for Telomir Pharmaceuticals, Inc. - Common Stock is TELO on the Nasdaq Stock Market
    What is the current price of Telomir Pharmaceuticals, Inc. - Common Stock?
    The current price of Telomir Pharmaceuticals, Inc. - Common Stock is 1.360
    When was Telomir Pharmaceuticals, Inc. - Common Stock last traded?
    The last trade of Telomir Pharmaceuticals, Inc. - Common Stock was at 03/13/26 11:10 AM ET
    What is the market capitalization of Telomir Pharmaceuticals, Inc. - Common Stock?
    The market capitalization of Telomir Pharmaceuticals, Inc. - Common Stock is 46.76M
    How many shares of Telomir Pharmaceuticals, Inc. - Common Stock are outstanding?
    Telomir Pharmaceuticals, Inc. - Common Stock has 47M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.